论文部分内容阅读
肝衰竭的治疗是目前临床上亟待解决的难题。近几年人工肝支持系统(artificial liver support system,ALSS)已被应用于各种原因导致的肝功能衰竭的治疗中,由于治疗价格相对较贵,加之不同原因导致的肝衰竭其治疗效果及预后有很大的差异,临床评价不一。本文研究观察了在综合护肝治疗基础上应用ALSS治疗36例急、慢性肝功能衰竭(hepatic failure,HF)病人,将生存期、生活质量、副作用、医疗费用及疗效等作为判断病人最主要的指标来分析ALSS的综合临床效益。
The treatment of liver failure is currently a clinical problem to be solved. In recent years, artificial liver support system (ALSS) has been used in the treatment of liver failure caused by various reasons. Due to the relatively expensive treatment and the therapeutic and prognostic effects of liver failure due to various reasons There are big differences, different clinical evaluation. In this study, 36 patients with acute and chronic hepatic failure (HF) who were treated with ALSS on the basis of comprehensive hepatoprotective therapy were observed. Survival, quality of life, side effects, medical costs and efficacy were the most important factors in judging patients Indicators to analyze the comprehensive clinical benefit of ALSS.